PCM
CELZ icon

Perkins Capital Management’s Creative Medical Technology CELZ Stock Holding History

Perkins Capital Management’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$4K – 100
2022
Q4 		$4K Hold
1,000
– – ﹤0.01% 99
2022
Q3 		$4K Sell
1,000
-1,375
-58% -$9.33K ﹤0.01% 104
2022
Q2 		$18K Hold
2,375
– – 0.02% 100
2022
Q1 		$93K Hold
2,375
– – 0.08% 100
2021
Q4 		$52K Buy
+2,375
New +$49.8K 0.04% 105

Other funds holding CELZ

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Perkins Capital Management's CELZ Position: Q1 2023 in Review

Perkins Capital Management sold out of Creative Medical Technology (CELZ) in Q1 2023, closing a stake of 1,000 shares — an estimated $4K sold.

Perkins Capital Management first reported a position in CELZ in Q4 2021 and held it in 5 quarters. The position peaked at $93K in Q1 2022. 15 funds tracked by Wall St. Rank hold CELZ as of Q1 2023.

  • Perkins Capital Management reported no remaining Creative Medical Technology position as of Q1 2023 after selling out during the quarter.
  • Perkins Capital Management sold 1,000 Creative Medical Technology shares in Q1 2023, an estimated $4K.
  • Perkins Capital Management first reported a position in Creative Medical Technology in Q4 2021 and held it in 5 quarters.
  • Perkins Capital Management's Creative Medical Technology position peaked at $93K in Q1 2022.
  • 15 funds tracked by Wall St. Rank held Creative Medical Technology as of Q1 2023.

Based on Perkins Capital Management's 13F filing for Q1 2023, filed 9 May 2023.